Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing

Plast Reconstr Surg. 2004 Nov;114(6):1502-8. doi: 10.1097/01.prs.0000138251.07040.51.

Abstract

Growth factors released from activated platelets initiate and modulate wound healing in both soft and hard tissues. A recent strategy to promote the wound-healing cascade is to prepare an autologous platelet concentrate suspended in plasma, also known as platelet-rich plasma, that contains growth factors and administer it to wound sites. The purpose of this study was to quantitate platelet number and growth factors released from a prepared platelet concentrate. Whole blood was drawn from 10 healthy patients undergoing cosmetic surgery and concentrated into platelet-rich plasma. Platelet counts on whole blood and platelet-rich plasma were determined using a Cell-Dyn 3200. Platelet-derived growth factor-BB, transforming growth factor-beta1, vascular endothelial growth factor, endothelial growth factor, and insulin-like growth factor-1 were measured in the platelet-rich plasma using the enzyme-linked immunosorbent assay method. In addition, platelet activation during the concentration procedure was analyzed by measuring P selectin values in blood serum. An 8-fold increase in platelet concentration was found in the platelet-rich plasma compared with that of whole blood (baseline whole blood, 197 +/- 42 x 10 platelets/microl; platelet concentrate, 1600 +/- 330 x 10 platelets/microl). The concentration of growth factors also increased with increasing platelet number. However, growth factor concentration varied from patient to patient. On average for the whole blood as compared with platelet-rich plasma, the platelet-derived growth factor-BB concentration increased from 3.3 +/- 0.9 ng/ml to 17 +/- 8 ng/ml, transforming growth factor-beta1 concentration increased from 35 +/- 8 ng/ml to 120 +/- 42 ng/ml, vascular endothelial growth factor concentration increased from 155 +/- 110 pg/ml to 955 +/- 1030 pg/ml, and endothelial growth factor concentration increased from 129 +/- 61 pg/ml to 470 +/- 320 pg/ml. No increase was found for insulin-like growth factor-1. In addition, no increase in platelet activation occurred during the concentration procedure as determined by the platelet surface receptor P selectin (45 +/- 16 pg/ml to 52 +/- 11 pg/ml, p = 0.65). In conclusion, a variety of potentially therapeutic growth factors were detected and released from the platelets in significant levels in platelet-rich plasma preparations. Sufficient concentrates and release of these growth factors through autologous platelet gels may be capable of expediting wound healing in a variety of as yet undetermined specific wound applications.

MeSH terms

  • Adult
  • Becaplermin
  • Blood Platelets / physiology*
  • Enzyme-Linked Immunosorbent Assay
  • Epidermal Growth Factor / blood
  • Female
  • Growth Substances / blood*
  • Humans
  • Insulin-Like Growth Factor I / analysis
  • Male
  • Middle Aged
  • P-Selectin / analysis
  • Plasma
  • Platelet Count*
  • Platelet-Derived Growth Factor / analysis
  • Proto-Oncogene Proteins c-sis
  • Reconstructive Surgical Procedures
  • Transforming Growth Factor beta / blood
  • Vascular Endothelial Growth Factor A / blood
  • Wound Healing / physiology*

Substances

  • Growth Substances
  • P-Selectin
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • Becaplermin
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I